![KYIV, UKRAINE - MAY 28, 2020: Gastroenterology generic drug Omeprazole by TEVA, box and blisters closeup on white. Teva Pharmaceuticals is an American Stock Photo - Alamy KYIV, UKRAINE - MAY 28, 2020: Gastroenterology generic drug Omeprazole by TEVA, box and blisters closeup on white. Teva Pharmaceuticals is an American Stock Photo - Alamy](https://c8.alamy.com/comp/2C6A97H/kyiv-ukraine-may-28-2020-gastroenterology-generic-drug-omeprazole-by-teva-box-and-blisters-closeup-on-white-teva-pharmaceuticals-is-an-american-2C6A97H.jpg)
KYIV, UKRAINE - MAY 28, 2020: Gastroenterology generic drug Omeprazole by TEVA, box and blisters closeup on white. Teva Pharmaceuticals is an American Stock Photo - Alamy
![Attorney General Stein announces settlement finalization with Teva Pharmaceuticals and Allergan, over $180 million to go to North Carolina Attorney General Stein announces settlement finalization with Teva Pharmaceuticals and Allergan, over $180 million to go to North Carolina](https://gray-wect-prod.cdn.arcpublishing.com/resizer/dY631iRUNEHmry0_gOINjo74yX8=/1200x675/smart/filters:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/gray/NTZZMVWJCVHFXDGT7B7G5ZMBKQ.jpg)
Attorney General Stein announces settlement finalization with Teva Pharmaceuticals and Allergan, over $180 million to go to North Carolina
![ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business](https://mms.businesswire.com/media/20180914005613/en/678526/5/AJOVY+Image.jpg)
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
![Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America](https://community.aafa.org/fileSendAction/fcType/0/fcOid/510642830861510679/filePointer/510642830861510701/fodoid/510642830861510696/imageType/MEDIUM/inlineImage/true/Teva-announced-launch-of-new-daily-asthma-medicine.png)